IndraLab

Statements

USP19 inhibits pathogenic potential Th17 cells. 4 / 4
| 4
eidos
"Collectively , our findings indicate that USP19 selectively suppresses the pathogenic potential of Th17 cells and offer novel strategies for treating autoimmune diseases ."
34135062
eidos
"Collectively , our findings indicate that the USP19 selectively suppresses the pathogenic potential of Th17 cells and suggest strategies for treating autoimmune diseases ."
34135062
eidos
"Collectively , our findings indicate that the USP19 selectively suppresses the pathogenic potential of Th17 cells , and provides novel strategies for treating autoimmune diseases ."
34135062
eidos
"In line with our in vitro findings , these in vivo observations indicate that USP19 suppresses pathogenic potential of Th17 cells , and therefore ameliorates autoimmunity ."
34135062